Gregory Sullivan
Tonix Pharmaceuticals · Tonix Pharmaceuticals, Inc. · Medical Monitor
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gregory Sullivan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:45 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06045793 · Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)Tonix Pharmaceuticals, Inc. · terminated · Cocaine Use, Cocaine Intoxication, Cocaine Toxicity · study director
- Ph2NCT05686408 · Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)Tonix Pharmaceuticals, Inc. · completed · Depression, Depressive Disorder, Depressive Symptoms · study director
- Ph2NCT05679908 · A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic MigraineTonix Pharmaceuticals, Inc. · completed · Chronic Migraine, Chronic Migraine, Headache, Chronic Migraine Without Aura · study director
- Ph2NCT05372887 · Safety and Efficacy Study of TNX-102 SL in Participants With PTSDTonix Pharmaceuticals, Inc. · withdrawn · PTSD · study director
- Ph3NCT05273749 · A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With FibromyalgiaTonix Pharmaceuticals, Inc. · completed · Fibromyalgia · study director
- Ph2NCT04996056 · An Open-Label, Randomized Pilot Study Comparing the Safety of a Single Dose of TNX-1300 to Usual Care (UC) Alone for the Treatment of Signs and Symptoms of Acute Cocaine Intoxication in Male Emergency Department (ED) SubjectsTonix Pharmaceuticals, Inc. · withdrawn · Cocaine Intoxication · study director
- Ph3NCT04508621 · A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With FibromyalgiaTonix Pharmaceuticals, Inc. · completed · Fibromyalgia · study director
- Ph3NCT04172831 · A Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With FibromyalgiaTonix Pharmaceuticals, Inc. · completed · Fibromyalgia · study director
- Ph3NCT02015234 · 12-Month Open-Label Long-term Safety Study of TNX-102 SL Tablets in Fibromyalgia PatientsTonix Pharmaceuticals, Inc. · completed · Primary Fibromyalgia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Development of TNX-1300 (Double Mutant Cocaine Esterase) for the Treatment of Life-Threatening Cocaine IntoxicationU01DA056245 · NIDA · TONIX PHARMACEUTICALS, INC. · fiscal years 2022 to 2025 · $605,767 awarded in 2025Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 21:45 UTC. The ranking covers the 200 most relevant of 57 PubMed records, and a shared surname and initials can bring in a namesake. All 57 on PubMed
- Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.J Clin Endocrinol Metab · 20003,176 citationsRCR 88.0
- 326 citationsRCR 12.3
- A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.Arch Gen Psychiatry · 2005179 citationsRCR 6.5
- Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample.Depress Anxiety · 2012171 citationsRCR 6.5
- Who gets the most out of cognitive behavioral therapy for anxiety disorders? The role of treatment dose and patient engagement.J Consult Clin Psychol · 2013111 citationsRCR 5.2
- Perceived social support mediates anxiety and depressive symptom changes following primary care intervention.Depress Anxiety · 2014105 citationsRCR 5.0
- Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care.Arch Gen Psychiatry · 201197 citationsRCR 3.9
- Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior.Am J Psychiatry · 201193 citationsRCR 3.5
- Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.Neuropsychopharmacology · 200979 citationsRCR 2.5
- Design of the Coordinated Anxiety Learning and Management (CALM) study: innovations in collaborative care for anxiety disorders.Gen Hosp Psychiatry · 200778 citationsRCR 2.8